Cleared Special

K021395 - MODIFICATION TO 30 EXTENSION SET

K021395 is an FDA 510(k) clearance for MODIFICATION TO 30 EXTENSION SET, manufactured by Churchill Medical Systems, Inc.. The device is a Class 2 General Hospital device with product code FPA cleared through the Special 510(k) pathway after a 11-day FDA review.

K021395 · Churchill Medical Systems, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2002
Decision
11d
Days
Class 2
Risk

K021395 is an FDA 510(k) clearance for the MODIFICATION TO 30 EXTENSION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Churchill Medical Systems, Inc. (Dover, US). The FDA issued a Cleared decision on May 13, 2002 after a review of 11 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Churchill Medical Systems, Inc. devices

FDA 510(k) Submission Details - K021395

510(k) Number K021395 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 02, 2002
Decision Date May 13, 2002
Days to Decision 11 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
118d faster than avg
Panel avg: 129d · This submission: 11d
Pathway characteristics
Modification to existing cleared device.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 726
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K021395.
SIMPLICITY EASY P SOFT INFUSION SET FOR INFUSION AND/OR INJECTION OF FLUIDS INTO THE BODY BELOW THE SURFACE OF THE SKIN
K021530 · Sterling Medivations, Inc. · May 2002
SIMPLICITY EASY ACCESS P INFUSION SET
K021487 · Sterling Medivations, Inc. · May 2002
SIMPLICITY QD EASY P INFUSION SET
K021296 · Sterling Medivations, Inc. · May 2002
SIMPLICTY SIMPLEX P INFUSION SET FOR USE WITH THE MINIMED PARADIGM INFUSION PUMPS
K021216 · Sterling Medivations, Inc. · May 2002
SIMPLICITY EASY ACCESS II INFUSION SET FOR INFUSION AND/OR INJECTION OF FLUIDS INTO THE BODY BELOW THE SURFACE
K021005 · Sterling Medivations, Inc. · Apr 2002
BD SAF-T PRN LUER ACTIVATED VALVE, MODEL 385100
K013621 · Becton Dickinson Infusion Therapy Systems, Inc. · Apr 2002